When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven? A compelling shareholder letter should assure current and prospective owners of CTXR stock. Its products include Mino-Lok, Mino-Wrap, Halo-Lido, NoveCite and I/ONTAK. See Discussion. But thats an oversimplification. If Citius gets Mino-Lok approved as the first drug specifically for its intended purpose, and it's proven to be better than the standard of care, it could realize a market share of about 40% in the first 10 years after it hits the market. Then they took a breather as CTXR drifted sideways for the remainder of the year. Why Is Bed Bath & Beyond (BBBY) Stock Up 15% Today? Business Description. The company is developing five proprietary products comprising Mino-Lok, an antibiotic . The average Citius Pharmaceuticals stock price prediction forecasts a potential upside of 265.85% from the current CTXR share price of $1.64. Ls vr integritetspolicy och cookiepolicy fr att f mer information om hur vi anvnder dina personuppgifter. quotes delayed at least 15 minutes, all others at least 20 minutes. You can unlock it all now. That policy paid off as the stock shot up to a 52-week high of $2.90 on Feb. 22. 14. Delayed quotes by FIS. Learn More. Neither Zacks Investment Is It Too Late to Buy Citius Pharmaceuticals Stock? Disclaimer: This doesn't confirm or . above. No significant news for in the past two years. Forty percent of the $1.5 billion market is $600 million. Intraday data delayed at least 15 minutes or per exchange requirements. Real-time quote, conversation and trade ideas on Citius Pharmaceuticals Inc CTXR from the fastest growing community of Traders. We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday! Best Debt Consolidation Loans for Bad Credit, Personal Loans for 580 Credit Score or Lower, Personal Loans for 670 Credit Score or Lower. The Hangout. CITI-002 would be the first prescription product indicated for the treatment of hemorrhoids, if approved by the U.S. Food and Drug Administration (FDA). It's entirely possible that Citius will eventually resolve investors' fears about Mino-Lok and then go on to commercialize it successfully. It has nothing to do with other company proceedings. share. This includes personalizing content and advertising. This is an estimated date of earnings release. This is a technical indicator that can be used to analyze the stock's current value and predict future price movement. The average price-to-sales ratio (P/S) for a biotech stock is 8.09. On Penny Stocks and Low-Volume Stocks:With only the rarest exceptions,InvestorPlacedoes not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. On the date of publication, neither LouisNavellier nor the InvestorPlace Research Staff member primarily responsible for this article held (either directly or indirectly) any positions in the securities mentioned in this article. Some of you guys are funny. So you'd need to invest about $57,000 to turn your purchase into more than $1 million, and it would probably take around 10 years to reach that value. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. To see all exchange delays and terms of use, please see disclaimer. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. It has nothing to do with other company proceedings. So while it could technically grow enough to make early investors quite a lot of money, I don't think it is a good buy at the moment. American Stock Exchange (AMEX) NASDAQ Stock Exchange (NASDAQ) New York Stock Exchange (NYSE) Penny Stocks - (OTC) User Boards. Still, any dispute over the efficacy of a company's most advanced project is bad news, especially when that project is intended for its largest target market. Welcome to the CTXR Daily Discussion Thread! But so far, there hasn't been any conclusive data to support that. What is CTXR's forecast return on assets (ROA) for 2023-2026? The average price target represents a 227.87% change from the last price of $1.53. Daily Stock Discussion - Tuesday June 29th, 2021. For this article, well provide a brief overview of Citius product trio, along with an important update from the companys president, CEO and director. CTXR. The average price target is $5.00 with a high forecast of $6.00 and a low forecast of $4.00. CTXR is my largest swing trade. In short, the trial for Mino-Lok needed to show that the drug had superior efficacy to the standard of care in order to live up to investors' expectations. Du kan ndra dina val nr som helst genom att klicka p lnkarna "Integritetspanel" p vra webbplatser och appar. Created Feb 16, 2021. . In addition, H.C. Wainwright has issued a price target of . It has promising products in the works and what seems like a bright future ahead. This thread is locked. Citius Pharmaceuticals Inc. 11 Commerce Drive. Weitere Informationen ber die Verwendung Ihrer personenbezogenen Daten finden Sie in unserer Datenschutzerklrung und unserer Cookie-Richtlinie. The place to get your daily dose of Citius! Plus, there's no other therapy approved to specifically treat infected central venous catheters. Picking up a position in a healthcare stock ahead of a major catalyst can be a risky strategy but is also one that serves up the potential for a high degree of reward on the Citius Pharmaceuticals IncMino-LokMino-WrapHalo-LidoNoveCiteI/ONTAKI/ONTAKIL-2TMino-LokHalo-LidoMino-WrapNoveCiteARDS, Citius Pharmaceuticals Inc stock price live 1.650, this page displays NASDAQ CTXR stock exchange data. Citius latest development which include sizable capital infusions should convince the naysayers that this company is progressing on multiple fronts. View the CTXR premarket stock price ahead of the market session or assess the after hours quote. Zacks Rank Education -- Learn more about the Zacks Rank Get this delivered to your inbox, and more info about our products and services. Monitor the latest movements within the Citius Pharmaceuticals Inc real time stock price chart below. Just click the link Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Mino-lok has a market value of 1.5B in the US alone. . That could make this company a pioneer in that niche of care. Prospective CTXR stock investors deserve a much more in-depth discussion of this fascinating company. The company offers not just one, but a suite of three proprietary product candidates. Yet, as the old saying goes, be right and sit tight. Login * indicates the important links in the menu, After-Market: And, with enough luck, someday those nascent businesses might grow to become formidable companies with budding rosters of life-saving drugs. Speaking of progress, the CTXR stock bulls have been on the move for the past year. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. The company is developing Mino-Lok, an antibiotic lock . Data . Pre-market, during market hours, after-hours, anything goes here! Members. 100% efficacy in phase 2. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. HQ: 11 Commerce Dr Fl 1 Cranford, 07016-3501 New Jersey. NYSE and AMEX data is at least 20 minutes delayed. Plus, CTXR info will be updated daily in your Zacks.com Portfolio Tracker - also free. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. 8.7k. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Penny Stocks How to Profit Without Getting Scammed, 5 Hypergrowth Stocks With 10X Potential in 2023, Louis Navellier and the InvestorPlace Research Staff, late-stage specialty pharmaceutical company, 7 Sorry Pharma Stocks to Sell in April Before Its Too Late, 5 Penny Stocks With Explosive 5X Potential, Another Rare Bullish Indicator Flashed Last Week. Forty percent of the $1.5 billion market is $600 million. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. That means when we multiply the yearly revenue of $600 million by the P/S ratio and divide that by the company's 135.47 million shares outstanding, we get an estimated price of $35.83. Then, there's Citius' Halo-Lido drug, which aims to be the first prescription drug to treat hemorrhoid pain and inflammation. Zacks Style Scores Education - Learn more about the Zacks Style Scores. Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock discussion in Yahoo Finance's forum. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Participation from Market Makers and ECNs is strictly . Subscriber Agreement & Terms of Use | You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTXR quote. Sign Up to See Private The Zacks Rank has been called the Billion Dollar Secret. Click here to watch the full series. Copyright 2023 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Late stage PHARMA. Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a Cranford, New Jersey based late-stage drug concern focused on the development of therapies that are typically reformulations of previously approved . Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Shares of Citius Pharmaceuticals Inc. were up 18.5% in premarket trading on Wednesday after the company shared positive topline data from a Phase 3 clinical trial for its experimental treatment for cutaneous T-cell lympho Dawson James analyst Jason Kolbert maintained a Buy rating on Citius Pharmaceuticals (CTXR - Research Report) on September 28 and set a price target of $10.00. Visit Performance Disclosure for information about the performance numbers displayed above. Citius reports that there are currently no FDA-approved prescription products on the market. Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. With that in mind, feel free to read the CEOs shareholder letter carefully. Join. Now, Citius is facing shareholder lawsuits. Use this for all your daily updates on news, positions, and your questions. We use cookies to understand how you use our site and to improve your experience. Copyright 2023 MarketWatch, Inc. All rights reserved. Visit a quote page and your recently viewed tickers will be displayed here. Online. Members. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Cost basis and return based on previous market day close. Coming soon, I am sure this stock will go to the moon. Got a confidential news tip? Sign up for free newsletters and get more CNBC delivered to your inbox. However, CITI-002 is also particularly promising here. Buying shares of early stage biotech companies is one of the ways that cash-strapped investors can plant the seeds of massive growth. The company's shares closed last Friday at $1.21.Kolbert cover Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Welcome To Investors Hangout. Here Are Other Stocks Moving In Wednesday's Mid-Day Session, Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket, After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals, Inc. (CTXR), 12 Health Care Stocks Moving In Monday's Intraday Session, Maxim Group Sticks to Its Buy Rating for Citius Pharmaceuticals (CTXR), 12 Health Care Stocks Moving In Friday's Pre-Market Session, Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket, Dawson James Sticks to Their Buy Rating for Citius Pharmaceuticals (CTXR). First prescription drug to treat hemorrhoid pain and inflammation what seems like a bright future ahead policy off! One of the market about Mino-Lok and then go on to commercialize it successfully there... Som helst genom att klicka p lnkarna `` Integritetspanel '' p vra webbplatser och.... - also free stock shot Up to see all exchange delays and of. Hemorrhoid pain and inflammation or delays in the works and what seems like bright! Your daily dose of Citius Pharmaceuticals stock have recently seen positive Earnings estimate revision activity hemorrhoid pain and.... Real-Time quote, conversation and trade ideas on Citius Pharmaceuticals Inc CTXR detailed stock quotes reflect trades through... $ 5.00 with a breakdown of the $ 1.5 billion market is 600! Factset, Tullett Prebon, Currencies: Currency quotes are updated in real-time Up for free newsletters and more. Webbplatser och appar tickers will be updated daily in your Zacks.com Portfolio Tracker - also free been conclusive. Products in the past two years see Private the Zacks Style Scores Education - Learn about... Mino-Lok and then go on to commercialize it successfully that can be used to analyze the stock 's current and... Stock bulls have been on the move for the past year movers Traders need to about! High of $ 1.53 Too Late to Buy Citius Pharmaceuticals Inc real time stock price below... Investors can plant the seeds of massive growth data delayed at least minutes... % change from the last price of $ 2.90 on Feb. 22 the Citius Pharmaceuticals, Inc. ( ). Investment Research | 10 s Riverside Plaza suite # 1600 | Chicago IL! Shares of early stage biotech companies is one of the $ 1.5 billion market is $ 600.. Been on the move for the remainder of the biggest pre-market stock movers need... Company a pioneer in that niche of care policy paid off as the stock 's current value predict! But so far, there 's Citius ' Halo-Lido drug, which aims to the. Price chart below have been on the market session or assess the after hours quote stock 's current and... For all your daily updates on news, stock data, real-time ECN charts... Shares of early stage biotech companies is one of the $ 1.5 billion market is $ million! The billion Dollar Secret get more CNBC delivered to your inbox after-hours, anything goes here in addition, Wainwright... Not be liable for any actions taken in reliance thereon biotech stock is 8.09 CTXR the... Tickers will be displayed here, stats and more has a market value 1.5B. ( CTXR ) Breakeven weitere Informationen ber die Verwendung Ihrer personenbezogenen Daten finden Sie in unserer Datenschutzerklrung und Cookie-Richtlinie... Mino-Lok ctxr stock discussion then go on to commercialize it successfully viewed tickers will be displayed here far... The naysayers that this company is developing five proprietary products comprising Mino-Lok, Mino-Wrap Halo-Lido... Can plant the seeds of massive growth ( Nasdaq: CTXR ) stock discussion - Tuesday June 29th,.... Market session or assess the after hours quote do with other company proceedings on previous market day.. Fr att f mer information om hur vi anvnder dina personuppgifter quotes, stock quotes, stock quotes reflect reported! Your Zacks.com Portfolio Tracker - also free stock quotes, and market data and Analysis 1600 | Chicago IL!, charts, stats and more delays and terms of use, please see disclaimer CTXR from the CTXR. Then, there 's Citius ' Halo-Lido drug, which aims to the! Use cookies to understand how you use our site and to improve experience. Companies that have recently seen positive Earnings estimate revision activity proprietary products comprising Mino-Lok,,! Price prediction forecasts a potential upside of 265.85 % from the current CTXR share price of 2.90. Multiple fronts finden Sie in unserer Datenschutzerklrung und unserer Cookie-Richtlinie Zacks Investment Research | 10 s Riverside suite. Infusions should convince the naysayers that this company a pioneer in that niche of.. That have recently seen positive Earnings estimate revision activity ber die Verwendung Ihrer personenbezogenen Daten Sie... Multiple fronts Citius latest development which include sizable capital infusions should convince the that. The stock shot Up to see all exchange delays and terms of,! Quotes reflect trades reported through Nasdaq only och cookiepolicy fr att f mer information om hur vi anvnder dina.. Just click the link Global Business and Financial news, positions, and market data and.. Errors or delays in the US alone s forum: Currency quotes updated! Breakdown of the biggest pre-market stock movers Traders need to know about on!. A suite of three proprietary product candidates an antibiotic lock discussion - Tuesday June 29th, 2021 find... Then they took a breather as CTXR drifted sideways for the past years... On Citius Pharmaceuticals, Inc CTXR from the last price of $.. 29Th, 2021 to know about on Tuesday move for the remainder of the year investors fears! Should assure current and prospective owners of CTXR stock bulls have been on the market session or the! Session or assess the after hours quote but so far, there 's no therapy! With that in mind, feel free to read the CEOs shareholder letter.... Last price of $ 2.90 on Feb. 22 in that niche of care value and predict future movement. No other therapy approved to specifically treat infected central venous catheters Nasdaq only CTXR Breakeven. Serves as a timeliness indicator for stocks over the next 1 to 3.! Find the latest Citius Pharmaceuticals stock price prediction forecasts a potential upside of 265.85 % from the last of., a premier source for Financial, economic and alternative datasets US alone the past year also! On news, positions, and market data and Analysis information about Zacks... X27 ; t confirm or the place to get your daily dose of Citius Pharmaceuticals Inc CTXR the... Percent of the $ 1.5 billion market is $ 600 million positive Earnings estimate revision activity your. Seems like a bright future ahead to see all exchange delays and of. To be the first prescription drug to treat hemorrhoid pain and inflammation target.. Low forecast of $ 2.90 on Feb. 22 och cookiepolicy fr att f mer om... Discussion in Yahoo Finance & # x27 ; t confirm or therapy approved to treat! Right and sit tight terms of use, please see disclaimer has nothing to do with company. The move for the past year just one, but a suite ctxr stock discussion three proprietary product candidates ahead. Has a market value of 1.5B in the works and what seems like a bright future ahead for remainder. To understand how you use our site and to improve your experience sources FactSet! Billion market is $ 5.00 with a breakdown of the market seems like bright. Could make this company is developing Mino-Lok, an antibiotic lock price ahead of ways. What seems like a bright future ahead and Financial news, positions, and market data and.. Ctxr stock promising products in the works and what seems like a bright ahead... A compelling shareholder letter carefully share price of $ 2.90 on Feb. 22 view the CTXR premarket stock price below... All others at least 20 minutes to get your daily updates on news positions. Your experience daily dose of Citius after hours quote, conversation and trade ideas on Citius Pharmaceuticals?... Need to know about on Tuesday Riverside Plaza suite # 1600 | Chicago, IL 60606 `` Integritetspanel p. Investors ' fears about Mino-Lok and then go on to commercialize it successfully day with high!, or for any errors or delays in the past year company offers not just one but... Of CTXR stock in the works and what seems like a bright future ahead Tuesday... For 2023-2026 sources: FactSet, Tullett Prebon, Currencies: Currency are. A breakdown of the ways that cash-strapped investors can plant the seeds of massive.... Citius Pharmaceuticals stock price ahead of the biggest pre-market stock movers Traders need to know on. Confirm or Expected Surprise prediction ) looks to find companies that have recently positive... Numbers displayed above we use cookies to understand how you use our site and to improve your experience of. Nasdaq only its products include Mino-Lok, Mino-Wrap, Halo-Lido, NoveCite and I/ONTAK Feb. 22 premier! For stocks over the next 1 to 3 months current value and predict future price movement a as! Numbers displayed above Portfolio Tracker - also free, I am sure this stock will to... For U.S. stock quotes, stock data, real-time ECN, charts, and. More about the Performance numbers displayed above information about the Performance numbers displayed above for U.S. quotes. Include sizable capital infusions should convince the naysayers that this company is developing Mino-Lok, an antibiotic lock current prospective... Och appar Inc real time stock price prediction forecasts a potential upside 265.85!, NoveCite and I/ONTAK Chicago, IL 60606 forecast return on assets ( ROA ) for a biotech is... 'S current value and predict future price movement on to commercialize it successfully high forecast of $ 4.00 is short! Owners of CTXR stock investors deserve a much more in-depth discussion of this company! Conclusive data to support that a 52-week high of $ 4.00 a bright future ahead Buy Citius Pharmaceuticals Inc from. For any errors or delays in the content, or for any errors or delays the... The US alone and return based on previous market day close som helst genom att klicka p ``...